 Robin Voigt
Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 13 | 2021 | 305 | 2.720 |
Why?
| | Ethanol | 17 | 2019 | 138 | 2.290 |
Why?
| | Methamphetamine | 5 | 2013 | 47 | 1.800 |
Why?
| | Intestinal Mucosa | 12 | 2019 | 235 | 1.630 |
Why?
| | Colon | 9 | 2021 | 155 | 1.620 |
Why?
| | Dysbiosis | 8 | 2022 | 57 | 1.540 |
Why?
| | Intestines | 10 | 2022 | 114 | 1.490 |
Why?
| | Multiple System Atrophy | 2 | 2022 | 42 | 1.050 |
Why?
| | Central Nervous System Stimulants | 4 | 2013 | 57 | 1.040 |
Why?
| | Animals | 30 | 2022 | 5312 | 0.980 |
Why?
| | Circadian Clocks | 4 | 2021 | 28 | 0.950 |
Why?
| | Liver | 4 | 2017 | 214 | 0.940 |
Why?
| | Parkinson Disease | 6 | 2022 | 1180 | 0.920 |
Why?
| | Gastrointestinal Diseases | 2 | 2019 | 42 | 0.900 |
Why?
| | Conditioning, Operant | 2 | 2011 | 15 | 0.860 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2021 | 7 | 0.860 |
Why?
| | Central Nervous System Depressants | 4 | 2019 | 25 | 0.840 |
Why?
| | Membrane Glycoproteins | 2 | 2021 | 111 | 0.840 |
Why?
| | Veterans | 1 | 2022 | 81 | 0.830 |
Why?
| | Carrier Proteins | 2 | 2021 | 129 | 0.830 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2021 | 43 | 0.830 |
Why?
| | Liver Diseases, Alcoholic | 3 | 2017 | 45 | 0.810 |
Why?
| | Photoperiod | 4 | 2021 | 44 | 0.780 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 226 | 0.730 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 52 | 0.720 |
Why?
| | Microbiota | 5 | 2018 | 94 | 0.710 |
Why?
| | Intestinal Absorption | 2 | 2017 | 41 | 0.700 |
Why?
| | Binge Drinking | 1 | 2017 | 13 | 0.670 |
Why?
| | Association Learning | 3 | 2013 | 14 | 0.650 |
Why?
| | Chronobiology Disorders | 2 | 2017 | 14 | 0.650 |
Why?
| | Mice, Inbred C57BL | 10 | 2021 | 548 | 0.640 |
Why?
| | Immunity, Mucosal | 2 | 2019 | 29 | 0.610 |
Why?
| | CLOCK Proteins | 5 | 2017 | 30 | 0.600 |
Why?
| | Alcohol Drinking | 4 | 2019 | 86 | 0.600 |
Why?
| | Alcoholism | 4 | 2018 | 90 | 0.590 |
Why?
| | Gene Expression Profiling | 2 | 2017 | 183 | 0.570 |
Why?
| | Mice | 15 | 2021 | 1894 | 0.550 |
Why?
| | Fendiline | 1 | 2013 | 2 | 0.520 |
Why?
| | Male | 24 | 2021 | 17583 | 0.510 |
Why?
| | Calcium Channel Blockers | 1 | 2013 | 40 | 0.510 |
Why?
| | Space Perception | 1 | 2013 | 45 | 0.500 |
Why?
| | Inflammation | 4 | 2017 | 360 | 0.500 |
Why?
| | Permeability | 10 | 2021 | 143 | 0.490 |
Why?
| | Alcohol-Related Disorders | 1 | 2013 | 4 | 0.490 |
Why?
| | Behavior, Addictive | 2 | 2018 | 11 | 0.470 |
Why?
| | Epigenesis, Genetic | 1 | 2013 | 95 | 0.460 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 351 | 0.450 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2011 | 9 | 0.440 |
Why?
| | Mianserin | 1 | 2011 | 16 | 0.440 |
Why?
| | Extinction, Psychological | 1 | 2011 | 14 | 0.430 |
Why?
| | Baclofen | 1 | 2011 | 15 | 0.430 |
Why?
| | Rats, Sprague-Dawley | 5 | 2013 | 494 | 0.430 |
Why?
| | Humans | 29 | 2022 | 31481 | 0.420 |
Why?
| | GABA-B Receptor Agonists | 1 | 2010 | 2 | 0.420 |
Why?
| | Alzheimer Disease | 1 | 2021 | 1829 | 0.390 |
Why?
| | Feeding Behavior | 3 | 2019 | 122 | 0.370 |
Why?
| | Feces | 4 | 2017 | 82 | 0.370 |
Why?
| | Time Factors | 6 | 2019 | 1902 | 0.370 |
Why?
| | HIV Infections | 2 | 2017 | 951 | 0.360 |
Why?
| | Disease Models, Animal | 8 | 2019 | 832 | 0.340 |
Why?
| | Eating | 2 | 2018 | 61 | 0.330 |
Why?
| | Circadian Rhythm Signaling Peptides and Proteins | 2 | 2019 | 10 | 0.330 |
Why?
| | Stem Cells | 2 | 2017 | 52 | 0.320 |
Why?
| | Colon, Sigmoid | 2 | 2017 | 18 | 0.300 |
Why?
| | Cytochrome P-450 CYP2E1 | 3 | 2014 | 13 | 0.300 |
Why?
| | Rats | 4 | 2011 | 966 | 0.290 |
Why?
| | Butyrates | 2 | 2022 | 20 | 0.280 |
Why?
| | Diet, High-Fat | 2 | 2015 | 27 | 0.280 |
Why?
| | Period Circadian Proteins | 4 | 2021 | 24 | 0.270 |
Why?
| | Motor Activity | 4 | 2021 | 397 | 0.250 |
Why?
| | Acute-Phase Proteins | 2 | 2021 | 15 | 0.240 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2022 | 12 | 0.230 |
Why?
| | Neurosecretory Systems | 1 | 2022 | 14 | 0.230 |
Why?
| | Bacteria | 1 | 2022 | 74 | 0.220 |
Why?
| | alpha-Synuclein | 2 | 2015 | 147 | 0.220 |
Why?
| | Toll-Like Receptor 4 | 2 | 2018 | 32 | 0.220 |
Why?
| | Fatty Liver | 2 | 2018 | 40 | 0.210 |
Why?
| | Oxidative Stress | 4 | 2017 | 140 | 0.210 |
Why?
| | Osteoarthritis, Knee | 2 | 2015 | 366 | 0.210 |
Why?
| | Carcinogenesis | 2 | 2019 | 27 | 0.200 |
Why?
| | Memory, Short-Term | 1 | 2021 | 99 | 0.200 |
Why?
| | Life Style | 1 | 2022 | 219 | 0.200 |
Why?
| | Analysis of Variance | 2 | 2011 | 364 | 0.200 |
Why?
| | Cartilage, Articular | 2 | 2015 | 586 | 0.200 |
Why?
| | Xeroderma Pigmentosum Group A Protein | 1 | 2019 | 4 | 0.190 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2017 | 52 | 0.190 |
Why?
| | Chronotherapy | 1 | 2019 | 6 | 0.190 |
Why?
| | Colonic Polyps | 1 | 2019 | 36 | 0.190 |
Why?
| | Rotenone | 1 | 2018 | 11 | 0.180 |
Why?
| | Ileum | 2 | 2017 | 31 | 0.180 |
Why?
| | Bacterial Translocation | 2 | 2015 | 35 | 0.170 |
Why?
| | Animal Feed | 1 | 2017 | 6 | 0.170 |
Why?
| | Organoids | 1 | 2017 | 10 | 0.170 |
Why?
| | Biopsy | 2 | 2017 | 283 | 0.170 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2017 | 19 | 0.170 |
Why?
| | Saliva | 1 | 2018 | 62 | 0.170 |
Why?
| | Hypercholesterolemia | 1 | 2018 | 39 | 0.170 |
Why?
| | Female | 9 | 2021 | 18253 | 0.170 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 36 | 0.170 |
Why?
| | Neoplasms | 1 | 2020 | 280 | 0.160 |
Why?
| | Aged | 5 | 2021 | 10295 | 0.160 |
Why?
| | Intestinal Diseases | 1 | 2017 | 11 | 0.160 |
Why?
| | Intestine, Small | 1 | 2017 | 37 | 0.160 |
Why?
| | Amphetamine-Related Disorders | 2 | 2013 | 10 | 0.160 |
Why?
| | Cytomegalovirus Infections | 1 | 2017 | 84 | 0.160 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 30 | 0.150 |
Why?
| | DNA-Binding Proteins | 1 | 2018 | 264 | 0.150 |
Why?
| | Signal Transduction | 1 | 2019 | 588 | 0.150 |
Why?
| | Carbohydrate Metabolism | 1 | 2015 | 8 | 0.140 |
Why?
| | Carbohydrates | 1 | 2015 | 13 | 0.140 |
Why?
| | Chromatography, Gas | 1 | 2015 | 12 | 0.140 |
Why?
| | Urinalysis | 1 | 2015 | 10 | 0.140 |
Why?
| | Colorectal Neoplasms | 1 | 2016 | 125 | 0.140 |
Why?
| | Dietary Sucrose | 1 | 2014 | 8 | 0.140 |
Why?
| | Joints | 1 | 2015 | 101 | 0.130 |
Why?
| | Anti-Infective Agents, Local | 1 | 2015 | 50 | 0.130 |
Why?
| | Rotarod Performance Test | 1 | 2013 | 10 | 0.130 |
Why?
| | Avoidance Learning | 1 | 2013 | 10 | 0.130 |
Why?
| | Light | 1 | 2014 | 77 | 0.130 |
Why?
| | Hepatitis, Alcoholic | 1 | 2013 | 10 | 0.130 |
Why?
| | Hippocampus | 1 | 2015 | 295 | 0.120 |
Why?
| | Treatment Outcome | 1 | 2022 | 3910 | 0.120 |
Why?
| | Cognition | 1 | 2021 | 1206 | 0.120 |
Why?
| | Knee Joint | 2 | 2015 | 775 | 0.120 |
Why?
| | Endotoxins | 1 | 2011 | 27 | 0.110 |
Why?
| | Receptors, GABA-B | 1 | 2011 | 3 | 0.110 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2011 | 17 | 0.110 |
Why?
| | Memory | 1 | 2013 | 343 | 0.110 |
Why?
| | Psychotherapy | 1 | 2011 | 44 | 0.110 |
Why?
| | Self Administration | 1 | 2011 | 38 | 0.110 |
Why?
| | Brain | 3 | 2022 | 1655 | 0.110 |
Why?
| | Adult | 5 | 2018 | 9779 | 0.100 |
Why?
| | Cyclopentanes | 1 | 2010 | 4 | 0.100 |
Why?
| | Phenols | 1 | 2010 | 10 | 0.100 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 257 | 0.100 |
Why?
| | Pyrimidines | 1 | 2010 | 31 | 0.100 |
Why?
| | Osteoarthritis | 1 | 2015 | 369 | 0.100 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2011 | 84 | 0.100 |
Why?
| | Aged, 80 and over | 1 | 2021 | 5234 | 0.100 |
Why?
| | Middle Aged | 5 | 2017 | 11209 | 0.100 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2019 | 27 | 0.090 |
Why?
| | Neurons | 1 | 2011 | 407 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2019 | 101 | 0.080 |
Why?
| | Environment | 2 | 2015 | 56 | 0.070 |
Why?
| | Endotoxemia | 2 | 2015 | 29 | 0.070 |
Why?
| | Cells, Cultured | 2 | 2017 | 802 | 0.070 |
Why?
| | Proteoglycans | 2 | 2015 | 419 | 0.060 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2021 | 15 | 0.050 |
Why?
| | Luciferases | 1 | 2021 | 24 | 0.050 |
Why?
| | Colitis | 1 | 2019 | 34 | 0.050 |
Why?
| | DNA Damage | 1 | 2019 | 33 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2019 | 308 | 0.050 |
Why?
| | Keratin-20 | 1 | 2017 | 5 | 0.040 |
Why?
| | Occludin | 1 | 2017 | 13 | 0.040 |
Why?
| | Chromogranin A | 1 | 2017 | 14 | 0.040 |
Why?
| | Jejunum | 1 | 2017 | 14 | 0.040 |
Why?
| | Receptor, Notch1 | 1 | 2017 | 10 | 0.040 |
Why?
| | Free Radical Scavengers | 1 | 2017 | 13 | 0.040 |
Why?
| | Protein Kinases | 1 | 2017 | 16 | 0.040 |
Why?
| | DNA, Ribosomal | 1 | 2017 | 12 | 0.040 |
Why?
| | Cell Lineage | 1 | 2017 | 34 | 0.040 |
Why?
| | Cadherins | 1 | 2017 | 38 | 0.040 |
Why?
| | DNA, Bacterial | 1 | 2017 | 54 | 0.040 |
Why?
| | Fatty Acids | 1 | 2017 | 45 | 0.040 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 81 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2018 | 399 | 0.040 |
Why?
| | DNA, Viral | 1 | 2017 | 107 | 0.040 |
Why?
| | Protein Kinase Inhibitors | 1 | 2017 | 67 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2017 | 188 | 0.040 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2017 | 18 | 0.040 |
Why?
| | Viral Load | 1 | 2017 | 213 | 0.040 |
Why?
| | Mast Cells | 1 | 2016 | 45 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2018 | 687 | 0.040 |
Why?
| | Young Adult | 2 | 2015 | 2277 | 0.040 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2015 | 36 | 0.040 |
Why?
| | Organ Specificity | 1 | 2015 | 58 | 0.040 |
Why?
| | Protein Folding | 1 | 2015 | 26 | 0.040 |
Why?
| | Cytokines | 1 | 2017 | 364 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 46 | 0.040 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 38 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2015 | 80 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 2015 | 29 | 0.040 |
Why?
| | Body Weight | 1 | 2015 | 167 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2015 | 50 | 0.030 |
Why?
| | Probiotics | 1 | 2015 | 18 | 0.030 |
Why?
| | Fatty Liver, Alcoholic | 1 | 2014 | 12 | 0.030 |
Why?
| | Homeostasis | 1 | 2015 | 110 | 0.030 |
Why?
| | Kinetics | 1 | 2015 | 278 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 138 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2015 | 128 | 0.030 |
Why?
| | Smoking | 1 | 2015 | 202 | 0.030 |
Why?
| | Caco-2 Cells | 1 | 2013 | 53 | 0.030 |
Why?
| | Mutation | 1 | 2015 | 464 | 0.030 |
Why?
| | Disease Progression | 1 | 2015 | 861 | 0.030 |
Why?
| | Obesity | 1 | 2015 | 338 | 0.030 |
Why?
| | Sucrose | 1 | 2011 | 19 | 0.030 |
Why?
| | Body Mass Index | 1 | 2015 | 458 | 0.030 |
Why?
| | Tyrosine | 1 | 2011 | 28 | 0.030 |
Why?
| | Immunoenzyme Techniques | 1 | 2011 | 54 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2013 | 371 | 0.030 |
Why?
| | Escherichia coli Infections | 1 | 2011 | 32 | 0.030 |
Why?
| | Escherichia coli | 1 | 2011 | 66 | 0.030 |
Why?
| | Receptor, Metabotropic Glutamate 5 | 1 | 2011 | 15 | 0.030 |
Why?
| | Chronic Disease | 1 | 2011 | 544 | 0.020 |
Why?
| | Aging | 1 | 2015 | 1614 | 0.020 |
Why?
|
|
Voigt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|